Month: November 2016
21st Century Cures Act Fails to Address Off-Label Marketing
The House of Representatives passed the 21st Century Cures Act, sending it to the Senate. Lawmakers eliminated a provision addressing the "off-label" marketing debate raging between the FDA and the pharmaceutical industry.
Tests Find Glyphosate in 29 Snack Foods and Cereals
Roundup weed-killer residues were found in Cheerios, Doritos, Pita Chips, Oreos, and dozens of other American snack foods.
Trump Taps Obamacare Critic as Health Secretary
President-elect Donald Trump has named Tom Price, a healthcare expert and fierce critic of Obamacare, as his Health and Human Services (HHS) secretary.
LASIK Eye Surgeries May Cause New Vision Problems
Three months after LASIK eye surgery, nearly 50% of patients reported new vision problems they did not have before, according to a U.S. government study.
Arizona Man Files Cook Celect® IVC Filter Lawsuit
A man who was injured by a blood clot filter that is associated with high rates of perforation has filed a lawsuit against Cook Medical, joining over 1,175 similar lawsuits.
Bitcoin Basics: 5 Things You Need to Know About the World’s Most Popular Cryptocurrency
Bitcoin is changing the way monetary transactions are conducted on a global scale. Here are five things you need to know about the future of money in the digital age.
CVS Recalls Homeopathic Products for Kids Due to Belladonna
CVS recalls more homeopathic teething tablets and ear drops for kids after the FDA finds inconsistent amounts of belladonna, also known as "deadly nightshade."
Girl Who Got E. Coli At Petting Zoo Awarded $7.5 Million
A jury in Minnesota awarded $7.55 million on behalf of a 10 year-old girl who was infected with E. coli at a petting zoo on a pumpkin farm.
Season’s Beatings: Black Friday Deals Turn Holiday Shoppers into Crazed Animals
Black Friday kicked off this year’s annual orgy of seasonal spending, with bargains so great they brought out the worst in deal-crazed holiday shoppers.
FDA Pauses Oversight of Laboratory Developed Tests
FDA pauses stronger lab test regulations, setting its sights on an incoming Trump administration with the agency in its crosshairs.